Cited by 757Peptidase Inhibition and AnalysisImmune cells in cancerTGF-β signaling in diseases

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling

Yang, Xuguang, Lin, Yuli, Shi, Yinghong, Li, Bingji, Liu, Weiren, Yin, Wei, Dang, Yongjun, Chu, Yiwei, Fan, Jia, He, Rui·2016·Cancer Research

DOI 10.1158/0008-5472.can-15-2973

Published version of a preprint

Open this paper in CoChat — free account

Abstract

Cancer-associated fibroblasts (CAF) are components of the tumor microenvironment whose contributions to malignant progression are not fully understood. Here, we show that the fibroblast activation protein (FAP) triggers induction of a CAF subset with an inflammatory phenotype directed by STAT3 activation and inflammation-associated expression signature marked by CCL2 upregulation. Enforcing FAP expression in normal fibroblasts was sufficient to endow them with an inflammatory phenotype similar to FAP(+)CAFs. We identified FAP as a persistent activator of fibroblastic STAT3 through a uPAR-dependent FAK-Src-JAK2 signaling pathway. In a murine liver tumor model, we found that FAP(+)CAFs were a major source of CCL2 and that fibroblastic STAT3-CCL2 signaling in this setting promoted tumor growth by enhancing recruitment of myeloid-derived suppressor cells (MDSC). The CCL2 receptor CCR2 was expressed on circulating MDSCs in tumor-bearing subjects and FAP(+)CAF-mediated tumor promotion and MDSC recruitment was abrogated in Ccr2-deficient mice. Clinically, we observed a positive correlation between stromal expression of FAP, p-STAT3, and CCL2 in human intrahepatic cholangiocarcinoma, a highly aggressive liver cancer with dense desmoplastic stroma, where elevated levels of stromal FAP predicted a poor survival outcome. Taken together, our results showed how FAP-STAT3-CCL2 signaling in CAFs was sufficient to program an inflammatory component of the tumor microenvironment, which may hav…

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-15-2973

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cancer-related inflammation
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Fibroblasts in cancer
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Monocyte recruitment during infection and inflammation
Shi, C., & Pamer, E. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3070 · Cited by 3,015
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
Feig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Rhim, A. D., Oberstein, P. E., Thomas, D. H., Mirek, E. T., Palermo, C. F., Sastra, S. A., Dekleva, E. N., Saunders, T., Becerra, C. P., Tattersall, I. W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.021 · Cited by 2,085

Show all 44 references

Sorted by citations

Items 201–300 of 757

The roles of CC chemokines in response to radiation
Wang, L., Jiang, J., Chen, Y., Jia, Q., & Chu, Q. (2022) · Radiation Oncology · doi:10.1186/s13014-022-02038-x · Cited by 55
Fight the Cancer, Hit the CAF!
Papait, A., Romoli, J., Stefani, F. R., Chiodelli, P., Montresor, M. C., Agoni, L., Silini, A. R., & Parolini, O. (2022) · Cancers · doi:10.3390/cancers14153570 · Cited by 55
Dissecting FAP+ Cell Diversity in Pancreatic Cancer Uncovers an Interferon-Response Subtype of Cancer-Associated Fibroblasts with Tumor-Restraining Properties
Cumming, J., Maneshi, P., Dongre, M., Alsaed, T., Dehghan-Nayeri, M. J., Ling, A., Pietras, K., Patthey, C., & Öhlund, D. (2025) · Cancer Research · doi:10.1158/0008-5472.can-23-3252 · Cited by 61
Targeting the STAT3 oncogenic pathway: Cancer immunotherapy and drug repurposing
Dong, Y., Chen, J., Chen, Y., & Liu, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115513 · Cited by 59
Comprehensive single-cell aging atlas of healthy mammary tissues reveals shared epigenomic and transcriptomic signatures of aging and cancer
Angarola, B. L., Sharma, S. M., Katiyar, N., Kang, H. G., Nehar-Belaid, D., Park, S., Gott, R., Eryilmaz, G. N., LaBarge, M. A., Palucka, K., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00751-8 · Cited by 58
Role of Serine Proteases at the Tumor-Stroma Interface
Tagirasa, R., & Yoo, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.832418 · Cited by 58
Microenvironmental regulation in tumor progression: Interactions between cancer-associated fibroblasts and immune cells
Gao, D., Fang, L., Liu, C., Yang, M., Yu, X., Wang, L., Zhang, W., Sun, C., & Zhuang, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115622 · Cited by 52
Cancer-Associated Fibroblasts: Implications for Cancer Therapy
Maia, A. R. R., & Wiemann, S. (2021) · Cancers · doi:10.3390/cancers13143526 · Cited by 58
Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma
Sakai, T., Aokage, K., Neri, S., Nakamura, H., Nomura, S., Tane, K., Miyoshi, T., Sugano, M., Kojima, M., Fujii, S., et al. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.10.021 · Cited by 54
Cancer-associated fibroblasts in cholangiocarcinoma
Vaquero, J., Aoudjehane, L., & Fouassier, L. (2020) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000609 · Cited by 52
The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy
Piper, M., Mueller, A. C., & Karam, S. D. (2020) · Molecular Carcinogenesis · doi:10.1002/mc.23205 · Cited by 52
Modulation of the tumor microenvironment by natural agents: implications for cancer prevention and therapy
Zubair, H., Khan, M. A., Anand, S., Srivastava, S. K., Singh, S., & Singh, A. P. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.05.009 · Cited by 53
Underlying mechanisms and drug intervention strategies for the tumour microenvironment
Li, H., Zhou, L., Zhou, J., Li, Q., & Ji, Q. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01893-y · Cited by 51
Central Roles of STAT3-Mediated Signals in Onset and Development of Cancers: Tumorigenesis and Immunosurveillance
Hashimoto, S., Hashimoto, A., Muromoto, R., Kitai, Y., Oritani, K., & Matsuda, T. (2022) · Cells · doi:10.3390/cells11162618 · Cited by 51
Mesenchymal-myeloid interaction in the regulation of immunity
Cheung, T. S., & Dazzi, F. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.01.002 · Cited by 51
Immunotherapy of pancreatic cancer
Sunami, Y., & Kleeff, J. H. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.03.006 · Cited by 52
(+)-Borneol improves the efficacy of edaravone against DSS-induced colitis by promoting M2 macrophages polarization via JAK2-STAT3 signaling pathway
Zhang, X., Xu, F., Liu, L., Feng, L., Wu, X., Shen, Y., Sun, Y., Wu, X., & Xu, Q. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.10.002 · Cited by 50
Targeting and Reprograming Cancer-Associated Fibroblasts and the Tumor Microenvironment in Pancreatic Cancer
Sunami, Y., Boeker, V., & Kleeff, J. H. (2021) · Cancers · doi:10.3390/cancers13040697 · Cited by 56
Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies
Cao, H., Huang, T., Dai, M., Kong, X., Liu, H., Zheng, Z., Sun, G., Sun, G., Rong, D., Jin, Z., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.73949 · Cited by 51
At the Interface of Tumor-Associated Macrophages and Fibroblasts: Immune-Suppressive Networks and Emerging Exploitable Targets
Timperi, E., Croizer, H., Khantakova, D., Rana, M., Molgora, M., Guerriero, J. L., Mechta-Grigoriou, F., & Romano, E. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1690 · Cited by 49
Role of Helicobacter pylori infection in cancer‐associated fibroblast‐induced epithelial‐mesenchymal transition in vitro
Krzysiek-Mączka, G., Targosz, A., Szczyrk, U., Strzałka, M., Śliwowski, Z., Brzozowski, T., Czyż, J., & Ptak‐Belowska, A. (2018) · Helicobacter · doi:10.1111/hel.12538 · Cited by 49
PIPKI γ Regulates CCL2 Expression in Colorectal Cancer by Activating AKT-STAT3 Signaling
Xue, J., Ge, X., Zhao, W., Xue, L., Dai, C., Lin, F., & Peng, W. (2019) · Journal of Immunology Research · doi:10.1155/2019/3690561 · Cited by 49
Role and mechanism of fibroblast-activated protein-α expression on the surface of fibroblast-like synoviocytes in rheumatoid arthritis
Wang, Z., Wang, J., Lan, T., Zhang, L., Yan, Z., Zhang, N., Xu, Y., & Tao, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1135384 · Cited by 53
Cancer cachexia: molecular basis and therapeutic advances
Tan, Y., Xue, R., Pan, Y., he, Z., Hu, X., Li, Y., Li, K., Zhang, X., Bian, X.-W., & Wang, B. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02331-7 · Cited by 57
MCP‑1 targeting: Shutting off an engine for tumor development (Review)
Wang, L., Lan, J., Tang, J., & Luo, N. (2021) · Oncology Letters · doi:10.3892/ol.2021.13144 · Cited by 47
Recent advances in CAR-T cells therapy for colorectal cancer
Qin, X., Wu, F., Chen, C., & Li, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.904137 · Cited by 47
The importance of cancer-associated fibroblasts in targeted therapies and drug resistance in breast cancer
Zheng, J., & Hao, H. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1333839 · Cited by 49
Tissue fibroblasts are versatile immune regulators: An evaluation of their impact on the aging process
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102296 · Cited by 50
Paracrine signaling in cancer-associated fibroblasts: central regulators of the tumor immune microenvironment
Li, Y., Wang, L., Ma, W., Wu, J., Wu, Q., & Sun, C. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06744-4 · Cited by 49
Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine
Malenica, I., Donadon, M., & Lleò, A. (2020) · Cancers · doi:10.3390/cancers12082190 · Cited by 48
High expression of fibroblast activation protein (FAP) predicts poor outcome in high-grade serous ovarian cancer
Li, M., Cheng, X., Rong, R., Gao, Y., Tang, X., & Chen, Y. (2020) · BMC Cancer · doi:10.1186/s12885-020-07541-6 · Cited by 47
HIF‐1α is necessary for activation and tumour‐promotion effect of cancer‐associated fibroblasts in lung cancer
Zhang, Y., Bian, Y., Wang, Y., Wang, Y., Duan, X., Han, Y., Zhang, L., Wang, F., Gu, Z., & Qin, Z. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16556 · Cited by 47
Colorectal cancer cell intrinsic fibroblast activation protein alpha binds to Enolase1 and activates NF-κB pathway to promote metastasis
Yuan, Z., Hu, H., Zhu, Y., Zhang, W., Fang, Q., Qiao, T., Ma, T., Wang, M., Huang, R., Tang, Q., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03823-4 · Cited by 47
Cancer-associated fibroblast senescence and its relation with tumour-infiltrating lymphocytes and PD-L1 expressions in intrahepatic cholangiocarcinoma
Lan, C., Kitano, Y., Yamashita, Y., Yamao, T., Kajiyama, K., Yoshizumi, T., Fukuzawa, K., Sugimachi, K., Ikeda, Y., Takamori, H., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01569-6 · Cited by 47
Fibroblast Activation Protein Expression in Sarcomas
Crane, J. N., Graham, D. S., Mona, C. E., Nelson, S. D., Samiei, A., Dawson, D. W., Dry, S., Masri, M. G., Crompton, J. G., Benz, M., et al. (2023) · Sarcoma · doi:10.1155/2023/2480493 · Cited by 46
Assessing personalized responses to anti-PD-1 treatment using patient-derived lung tumor-on-chip
Veith, I., Nurmik, M., Mencattini, A., Damei, I., Lansche, C., Brosseau, S., Gropplero, G., Corgnac, S., Filippi, J., Poté, N., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101549 · Cited by 49
Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges
Li, W., Little, N., Park, J., Foster, C. A., Chen, J., & Lu, J. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00455 · Cited by 46
Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Patients With Newly Diagnosed Non-Small Cell Lung Cancer
Wu, J., Deng, H., Zhong, H., Wang, T., Rao, Z., Wang, Y., Chen, Y., & Zhang, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.924223 · Cited by 46
The Heterogeneity of the Tumor Microenvironment as Essential Determinant of Development, Progression and Therapy Response of Pancreatic Cancer
Group Young Researchers in Inflammatory Carcinogenesis, Wandmacher, A. M., Mehdorn, A., & Sebens, S. (2021) · Cancers · doi:10.3390/cancers13194932 · Cited by 48
Identification of cancer-associated fibroblasts subtypes in prostate cancer
Pan, J., Ma, Z., Лю, Б., Qian, H., Shao, X., Liu, J., Wang, Q., & Xue, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1133160 · Cited by 45
Fibroblast diversity and plasticity in the tumor microenvironment: roles in immunity and relevant therapies
Xu, Y., Li, W., Lin, S., Liu, B., Wu, P., & Li, L. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01204-2 · Cited by 50
Biomaterials with cancer cell-specific cytotoxicity: challenges and perspectives
Chu, Z., Wang, W., Zheng, W., Fu, W., Wang, Y., Wang, H., & Qian, H. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00636d · Cited by 45
Cellular and molecular mechanisms of gastrointestinal cancer liver metastases and drug resistance
Dong, D., Xue, Y., Xu, J., Yu, N. H., Liu, Z., & Sun, Y. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2024.101125 · Cited by 49
Chimeric Antigen Receptor-T Cells in Colorectal Cancer: Pioneering New Avenues in Solid Tumor Immunotherapy
Ouladan, S., & Orouji, E. (2025) · Journal of Clinical Oncology · doi:10.1200/jco-24-02081 · Cited by 48
Developing neobavaisoflavone nanoemulsion suppresses lung cancer progression by regulating tumor microenvironment
Ye, H., He, X., & Xu, F. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110369 · Cited by 45
CYP4F2-Catalyzed Metabolism of Arachidonic Acid Promotes Stromal Cell-Mediated Immunosuppression in Non–Small Cell Lung Cancer
Chen, X., Liu, Y., Wang, Y., Wang, C., Chen, X., Xiong, Y., Liu, L., Yuan, X., Tang, H., Shu, C., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4029 · Cited by 45
Senescence and Immunoregulation in the Tumor Microenvironment
Ruhland, M. K., & Alspach, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.754069 · Cited by 45
Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma
Zhou, L., Li, Y., Zheng, D., Zheng, Y., Cui, Y., Qin, L., Tang, Z., Peng, D., Wu, Q., Long, Y., et al. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200817 · Cited by 47
Metabolites and Immune Response in Tumor Microenvironments
Cortellino, S., & Longo, V. D. (2023) · Cancers · doi:10.3390/cancers15153898 · Cited by 43
Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection
Zhang, Y., Shi, S.-M., Yang, H., Yang, L., Wang, Z., Li, X., Yin, D., Shi, Y., Cao, Y., Dai, Z., et al. (2019) · Journal of Cancer · doi:10.7150/jca.26890 · Cited by 41
Self-citation
Upregulation of Mobility in Pancreatic Cancer Cells by Secreted S100A11 Through Activation of Surrounding Fibroblasts
Mitsui, Y., Tomonobu, N., Watanabe, M., Kinoshita, R., Sumardika, I. W., Chen, Y., Murata, H., Yamamoto, K.-I., Sadahira, T., Rodrigo, A. G. H., et al. (2019) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504019x15555408784978 · Cited by 41
Paracrine Crosstalk between Fibroblasts and ER+ Breast Cancer Cells Creates an IL1β-Enriched Niche that Promotes Tumor Growth
Chatterjee, S., Bhat, V., Berdnikov, A., Liu, J., Zhang, G., Buchel, E. W., Safneck, J. R., Marshall, A. J., Murphy, L. C., Postovit, L.-M. M., et al. (2019) · iScience · doi:10.1016/j.isci.2019.07.034 · Cited by 43
Doxorubicin pretreatment enhances FAPα/survivin co-targeting DNA vaccine anti-tumor activity primarily through decreasing peripheral MDSCs in the 4T1 murine breast cancer model
Geng, F., Bao, X., Dong, L., Guo, Q., Guo, J., Xie, Y., Zhou, Y., Yu, B., Wu, H., Wu, J., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1747350 · Cited by 41
Enhancing TNBC Chemo-immunotherapy via combination reprogramming tumor immune microenvironment with Immunogenic Cell Death
Wu, S., Liu, D., Li, W., Song, B., Chen, C., Chen, D., & Hu, H. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120333 · Cited by 41
Comprehensive description of the current breast cancer microenvironment advancements via single-cell analysis
Yan, X., Xie, Y., Yang, F., Hua, Y., Zeng, T., Sun, C., Yang, M., Huang, X., Wu, H., Fu, Z., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01949-z · Cited by 41
Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens
Hunt, A. L., Bateman, N. W., Barakat, W., Makohon‐Moore, S. C., Hood, B. L., Conrads, K. A., Zhou, M., Calvert, V. S., Pierobon, M., Loffredo, J., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102757 · Cited by 42
Gut microbiota and its therapeutic implications in tumor microenvironment interactions
Feng, P., Xue, X., Bukhari, I., Qiu, C., Li, Y., Zheng, P., & Mi, Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1287077 · Cited by 39
Intimate communications within the tumor microenvironment: stromal factors function as an orchestra
Cheng, B., Yu, Q., & Wang, W. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-022-00894-z · Cited by 43
Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy
Montori, M., Scorzoni, C., Argenziano, M. E., Balducci, D., BLASIO, F. D., Martini, F., Buono, T., Benedetti, A., Marzioni, M., & Maroni, L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216498 · Cited by 38
Cancer-associated fibroblasts in the tumor microenvironment: heterogeneity, crosstalk mechanisms, and therapeutic implications
Huang, Z., Chen, J., Zhu, T., Li, J., Ng, H. Y., Zhou, Y., Gu, X., Xu, S., & Jia, R. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02533-1 · Cited by 49
Mechanisms of Resistance to Checkpoint Blockade Therapy
Shi, H., Lan, J., & Yang, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3266-5_5 · Cited by 37
The role of myeloid‐derived suppressor cells in gastrointestinal cancer
Cui, C., Lan, P., & Fu, L. (2021) · 癌症：英文版 · doi:10.1002/cac2.12156 · Cited by 40
The Prognostic and therapeutic value and clinical implications of fibroblast activation protein-α as a novel biomarker in colorectal cancer
Kalaei, Z., Manafi‐Farid, R., Rashidi, B., Kiani, F. K., Zarei, A., Fathi, M., & Jadidi‐Niaragh, F. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01151-y · Cited by 37
Transcriptional memory inherited from donor cells is a developmental defect of bovine cloned embryos
Zhou, C., Zhang, J., Zhang, M., Wang, D., Ma, Y., Wang, Y., Wang, Y., Huang, Y., & Zhang, Y. (2019) · The FASEB Journal · doi:10.1096/fj.201900578rr · Cited by 37
Is the C-C Motif Ligand 2–C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?
Iwamoto, H., Izumi, K., & Mizokami, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239328 · Cited by 37
Tumor cell–released LC3 ‐positive EVs promote lung metastasis of breast cancer through enhancing premetastatic niche formation
Sun, X., Wang, X., Yan, C., Zheng, S., Gao, R., Huang, F., Wei, Y., Wen, Z., Chen, Y., Zhou, X., et al. (2022) · Cancer Science · doi:10.1111/cas.15507 · Cited by 36
Epigenetic regulation of chemokine ( CC ‐motif) ligand 2 in inflammatory diseases
Chen, Y., Liu, S., Wu, L., Liu, Y., Du, J., Luo, Z., Xu, J., Guo, L., & Liu, Y. F. (2023) · Cell Proliferation · doi:10.1111/cpr.13428 · Cited by 39
Cross-Talk Between Cancer and Its Cellular Environment—A Role in Cancer Progression
Turlej, E., Domaradzka, A., Radzka, J., Drulis‐Fajdasz, D., Kulbacka, J., & Gizak, A. (2025) · Cells · doi:10.3390/cells14060403 · Cited by 47
PARP Inhibition Activates STAT3 in Both Tumor and Immune Cells Underlying Therapy Resistance and Immunosuppression In Ovarian Cancer
Martincuks, A., Song, J., Kohut, A. Y., Zhang, C., Li, Y., Zhao, Q., Mak, E., Rodrı́guez-Rodrı́guez, L., Yu, H., & Cristea, M. C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.724104 · Cited by 38
FAPhigh α‐SMAlow cancer‐associated fibroblast‐derived SLPI protein encapsulated in extracellular vesicles promotes ovarian cancer development via activation of PI3K/AKT and downstream signaling pathways
Sun, L., Ke, M.-L., Wang, X., Yin, M., Wei, J., Xu, L., Tian, X., Wang, F., Zhang, H., Fu, S., et al. (2022) · Molecular Carcinogenesis · doi:10.1002/mc.23445 · Cited by 40
Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy
Allam, A. H., Yakou, M. H., Pang, L., Ernst, M., & Huynh, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.767939 · Cited by 38
Cancer-Associated Fibroblasts and Extracellular Matrix: Therapeutical Strategies for Modulating the Cholangiocarcinoma Microenvironment
Minini, M., & Fouassier, L. (2023) · Current Oncology · doi:10.3390/curroncol30040319 · Cited by 38
Fibroblast activation protein and the tumour microenvironment: challenges and therapeutic opportunities
Lee, H., & Al‐Ogaili, Z. (2025) · Oncology Reviews · doi:10.3389/or.2025.1617487 · Cited by 40
Translation of cancer immunotherapy from the bench to the bedside
Guo, Q., Huang, F., Gonçalves, C., Rincon, S. V. D., & Miller, W. H. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.001 · Cited by 35
Fibroblast Activation Protein (FAP) Overexpression Induces Epithelial–Mesenchymal Transition (EMT) in Oral Squamous Cell Carcinoma by Down-Regulating Dipeptidyl Peptidase 9 (DPP9)
Wu, Q., Zhao, M., Huang, G., Zheng, Z., Chen, Y., Zeng, W., & Lv, X. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s243417 · Cited by 35
Cancer-Associated Fibroblasts Facilitate Squamous Cell Carcinoma Lung Metastasis in Mice by Providing TGFβ-Mediated Cancer Stem Cell Niche
Shi, X., Luo, J., Weigel, K. J., Hall, S. C., Du, D., Wu, F., Rudolph, M. C., Zhou, H., Young, C. D., & Wang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.668164 · Cited by 35
Sulfonylurea receptor 1-expressing cancer cells induce cancer-associated fibroblasts to promote non-small cell lung cancer progression
Chen, H., Li, Z., Meng, Y., Qian, X., Fan, Y., Zhang, Q., Wang, C., Lin, F., Chen, B., Xu, L., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215611 · Cited by 35
Biomarkers in Tumor Microenvironment? Upregulation of Fibroblast Activation Protein-α Correlates with Gastric Cancer Progression and Poor Prognosis
Hu, M., Qian, C., Hu, Z., Fei, B., & Zhou, H. (2017) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2016.0159 · Cited by 35
Interaction of tumor‑associated macrophages with stromal and immune components in solid tumors: Research progress (Review)
Казакова, А., Sudarskikh, T., Kovalev, O. I., Kzhyshkowska, J. G., & Larionova, I. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5480 · Cited by 35
Hsa_circ_0009092/miR-665/NLK signaling axis suppresses colorectal cancer progression via recruiting TAMs in the tumor microenvironment
Song, J., Liu, Q., Han, L., Song, T., Huang, S., Zhang, X., He, Q., Liang, C., Zhu, S., & Xiong, B. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02887-8 · Cited by 36
Targeting the Tumor Microenvironment in Breast Cancer: Prognostic and Predictive Significance and Therapeutic Opportunities
Dominguez-Cejudo, M. A., Gil-Torralvo, A., Solís, M. C., Molina‐Pinelo, S., & Bofill, J. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316771 · Cited by 42
FAP expression in adipose tissue macrophages promotes obesity and metabolic inflammation
Wu, Y., Wu, C., Shi, T., Cai, Q., Wang, T., Xiong, Y., Zhang, Y., Jiang, W., Lu, M., Chen, Z., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2303075120 · Cited by 35
Self-citation
Targeting focal adhesion kinase boosts immune response in KRAS/LKB1 co-mutated lung adenocarcinoma via remodeling the tumor microenvironment
Qiao, M., Zhou, F., Liu, X., Jiang, T., Wang, H., Li, X., Zhao, C., Cheng, L., Chen, X., Ren, S., et al. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00471-6 · Cited by 35
Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma
Kim, Y., Rhee, H., Yoo, J. E., Alves, V. A. F., Kim, G. J., Kim, H. M., Herman, P., Chagas, A. L., Kim, H., & Park, Y. N. (2017) · Histopathology · doi:10.1111/his.13219 · Cited by 34
Understanding and Targeting Natural Killer Cell-Cancer-Associated Fibroblast Interactions in Pancreatic Ductal Adenocarcinoma
Malchiodi, Z. X., & Weiner, L. M. (2021) · Cancers · doi:10.3390/cancers13030405 · Cited by 34
PET/CT Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients
Rong, X., Jin-yu, L., Liu, Y., Wang, Z., Zeng, D., Li, Y., Li, S., Wu, J., Shen, Z., Shi, M., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.802257 · Cited by 34
Fibroblast activation protein in the tumor microenvironment predicts outcomes of PD-1 blockade therapy in advanced non-small cell lung cancer
Zhao, Y., Liu, Y., Jia, Y., Wang, X., He, J., Zhen, S., Wang, J., & Liu, L. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04250-4 · Cited by 34
Immune Resistance Mechanisms and the Road to Personalized Immunotherapy
Piper, M., Kluger, H. M., Ruppin, E., & Hu‐Lieskovan, S. (2023) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_390290 · Cited by 34
Single‐cell RNA sequencing to explore cancer‐associated fibroblasts heterogeneity: “Single” vision for “heterogeneous” environment
Zhang, X., Zhu, R., Yu, D., Wang, J., Yan, Y., & Xu, K. (2023) · Cell Proliferation · doi:10.1111/cpr.13592 · Cited by 35
Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibition
Daly, R. J., Scott, A. M., Klein, O., & Ernst, M. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01656-z · Cited by 35
Heterogeneity of Cholangiocarcinoma Immune Biology
Vita, F., Olaizola, I., Amato, F., Rae, C. J., Marco, S., Bañales, J. M., & Braconi, C. (2023) · Cells · doi:10.3390/cells12060846 · Cited by 38
Ruthenium(ii)–Arene Complex Triggers Immunogenic Ferroptosis for Reversing Drug Resistance
Lv, M., Zheng, Y., Dai, X., Zhao, J., Hu, G., Ren, M., Shen, Z., Su, Z. G., Wu, C., Liu, H., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01467 · Cited by 33
Cancer associated fibroblasts tailored tumor microenvironment of therapy resistance in gastrointestinal cancers
Sun, Y., Wang, R., Qiao, M., Yan-chun, X., Guan, W., & Wang, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26433 · Cited by 32
Stress responses in stromal cells and tumor homeostasis
Vitale, I., Manic, G., Galassi, C., & Galluzzi, L. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.004 · Cited by 33
Overcoming Stromal Barriers to Immuno-Oncological Responses via Fibroblast Activation Protein-Targeted Therapy
Brennen, W. N., Thorek, D. L. J., Jiang, W., Krueger, T. E. G., Antony, L., Denmeade, S. R., & Isaacs, J. T. (2020) · Immunotherapy · doi:10.2217/imt-2020-0066 · Cited by 33
The Extracellular Matrix Environment of Clear Cell Renal Cell Carcinoma Determines Cancer Associated Fibroblast Growth
Bond, K., Chiba, T., Wynne, K. J., Vary, C., Sims‐Lucas, S., Coburn, J. M., & Oxburgh, L. H. (2021) · Cancers · doi:10.3390/cancers13235873 · Cited by 38
Heterogeneity of Cancer-Associated Fibroblasts and the Tumor Immune Microenvironment in Pancreatic Cancer
Shinkawa, T., Ohuchida, K., & Nakamura, M. (2022) · Cancers · doi:10.3390/cancers14163994 · Cited by 32
Response Prediction Using18F-FAPI-04 PET/CT in Patients with Esophageal Squamous Cell Carcinoma Treated with Concurrent Chemoradiotherapy
Hu, X., Zhou, T., Ren, J., Duan, J., Wu, H., Liu, X., Mu, Z., Liu, N., Wei, Y., & Yuan, S. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264638 · Cited by 32
From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment
Zhang, Z., Tao, J., Qiu, J., Cao, Z., Huang, H., Xiao, J., & Zhang, T. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00872-z · Cited by 31
Lobular Carcinoma of the Breast: A Comprehensive Review with Translational Insights
Batra, H. V., Mouabbi, J. A., Ding, Q., Şahin, A. A., & Raso, M. G. (2023) · Cancers · doi:10.3390/cancers15225491 · Cited by 35

Authors: Yang, X., Lin, Y., Shi, Y., Li, B., Liu, W., Yin, W., Dang, Y., Chu, Y., Fan, J., & He, R.
Affiliations: Shanghai Medical College of Fudan University (CN)
ORCID: Yang, Xuguang
Lin, Yuli
Li, Bingji
Liu, Weiren
Yin, Wei
Dang, Yongjun
Chu, Yiwei
Fan, Jia
He, Rui
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2016-07-14
Volume: 76
Issue: 14
Pages: 4124-4135
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-15-2973
OpenAlex: W2400022769
Cited by: 748
References: 44
Citations by year: 2026: 66 · 2025: 101 · 2024: 107 · 2023: 115 · 2022: 91 · 2021: 95 · 2020: 67 · 2019: 47 · 2018: 31 · 2017: 25 · 2016: 3
FWCI: 19.03
Type: journal article
Language: en
Open access: closed
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
Funders: NSFC (813220437, 81471555, 81272389)
National Key Sci-Tech Project (2012ZX10002011-002)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords: fibroblast activation protein, cancer-associated fibroblasts, tumor microenvironment, STAT3 signaling, MCP-1, CCR2, myeloid-derived suppressor cells, uPAR, desmoplasia, intrahepatic cholangiocarcinoma, liver cancer, immunosuppression, tumor stroma
MeSH terms: Cancer-Associated Fibroblasts, Fibroblast Activation Protein Alpha, Animals, Cell Movement, Female, Immune Tolerance, Membrane Proteins, Mice, Inbred C57BL, Endopeptidases, Serine Endopeptidases, Signal Transduction, Gelatinases, Chemokine CCL2, STAT3 Transcription Factor, Mice, Focal Adhesion Protein-Tyrosine Kinases, Janus Kinase 2, Receptors, Urokinase Plasminogen Activator, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks